Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 13/20 | 0.70 |
| ▸ | PKM | P14618 | 1/20 | 0.70 |
| ▸ | HTT | P42858 | 1/20 | 0.70 |
| ▸ | MAPT | P10636 | 8/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.69 |
| ▸ | MEN1 | O00255 | 3/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | CASP3 | P42574 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.62 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.62 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19988422 | 1.00 | ALDH1A1 (0.70) | ALDH1A1PKMHTTMAPTKDM4E | |
| SCHEMBL3602305 | 1.00 | ALDH1A1 (0.70) | ALDH1A1PKMHTTMAPTKDM4E | |
| SCHEMBL2139676 | 0.91 | ALDH1A1 (0.81) | ALDH1A1PKMHTTMAPTKDM4E | |
| SCHEMBL2139678 | 0.91 | ALDH1A1 (0.81) | ALDH1A1PKMHTTMAPTKDM4E | |
| SCHEMBL4317761 | 0.91 | ALDH1A1 (0.81) | ALDH1A1PKMHTTMAPTKDM4E | |
| SCHEMBL19011313 | 0.90 | ALDH1A1 (0.59) | ALDH1A1PKMHTTMAPTKDM4E | |
| SCHEMBL17329465 | 0.90 | ALDH1A1 (0.71) | ALDH1A1PKMHTTMAPTKDM4E | |
| SCHEMBL15371840 | 0.90 | ALDH1A1 (0.71) | ALDH1A1PKMHTTMAPTKDM4E | |
| SCHEMBL7866449 | 0.89 | ALDH1A1 (0.64) | ALDH1A1PKMHTTMAPTKDM4E | |
| SCHEMBL7866447 | 0.89 | ALDH1A1 (0.64) | ALDH1A1PKMHTTMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118076133-A | Composite material, composition, preparation method of composite material, light-emitting device and display device | TCL科技集团股份有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-120136926-A | Catalyst for condensation reaction of aldehyde and ethyl cyanoacetate Knoevenagel and preparation method thereof | 河北松辰医药科技有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-118076133-A | Composite material, composition, preparation method of composite material, light-emitting device and display device | TCL科技集团股份有限公司 | 2024-05-24 | — | — | CN | disclosed |
| EP-3553097-B1 | COPOLYMER AND OPTICAL FILM USING SAME | TOSOH CORP (JP) | 2022-05-04 | — | — | EP | disclosed |
| CN-113999232-A | MAT2A inhibitors | 南京正大天晴制药有限公司 | 2022-02-01 | — | — | CN | disclosed |
| US-11225540-B2 | Copolymer and optical film using same | TOSOH CORPORATION (JP) | 2022-01-18 | — | — | US | disclosed |
| CN-110248971-B | Copolymer and optical film using the same | 东曹株式会社 | 2021-11-02 | — | — | CN | disclosed |
| CN-113416191-A | Method for synthesizing tricyclic framework 2-pyridone/2-pyridine imine compound | 西安交通大学 | 2021-09-21 | — | — | CN | disclosed |
| US-20200095358-A1 | COPOLYMER AND OPTICAL FILM USING SAME | TOSOH CORPORATION (JP) | 2020-03-26 | — | — | US | disclosed |
| EP-3553097-A1 | COPOLYMER AND OPTICAL FILM USING SAME | Tosoh Corporation (JP) | 2019-10-16 | — | — | EP | disclosed |
| CN-109970655-A | Out-phase basic catalyst and α based on the out-phase basic catalyst, β-unsaturated compound continuous flow preparation method | 华侨大学 | 2019-07-05 | — | — | CN | disclosed |
| US-7947707-B2 | Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2011-05-24 | — | — | US | disclosed |
| US-20100063080-A1 | CXCR2 inhibitors | PRESS NEIL JOHN | 2010-03-11 | — | — | US | disclosed |
| US-20090306396-A1 | NITROGENATED HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2009-12-10 | — | — | US | disclosed |
| EP-2086947-A1 | PYRIMIDINES AND THEIR USE AS CXCR2 RECEPTOR ANTAGONISTS | Novartis AG (CH) | 2009-08-12 | — | — | EP | disclosed |
| WO-2008061740-A1 | PYRIMIDINES AND THEIR USE AS CXCR2 RECEPTOR ANTAGONISTS | NOVARTIS AG (CH) | 2008-05-29 | — | — | WO | disclosed |
| EP-0901512-A1 | DETERGENT COMPOSITION | UNILEVER PLC (GB) | 1999-03-17 | — | — | EP | disclosed |
| WO-1997044422-A1 | DETERGENT COMPOSITION | UNILEVER PLC (GB) | 1997-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306396-A1 | NITROGENATED HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | XDH, CBR3, CBR1 | ALDH1A1 280/4885PKM 2347/4885HTT 2813/4885 |
| US-20100063080-A1 | CXCR2 inhibitors | CXCR2, CXCR1, CXCR3 | ALDH1A1 931/4885PKM 4225/4885HTT 4202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.